Efficacy of chitosan-based material for hemostasis of orofacial incisions: A randomised controlled trial

In surgeries involving the face and mouth, controlling bleeding effectively is crucial due to the high number of blood vessels in these areas. Traditional methods and materials to stop bleeding can sometimes be slow, ineffective, or cause side effects. This research focuses on a new type of material made from chitosan, a natural substance derived from the shells of crustaceans like shrimp and crabs, known for its ability to quickly stop bleeding and being safe for use in the body.

The study aims to test how well chitosan-based materials work in controlling bleeding during and after oral and facial surgeries. The research will compare the new chitosan material with conventional hemostatic agents to see which one works better, how quickly they stop the bleeding, and if they cause any adverse reactions. The goal is to gather scientific evidence that could prove the chitosan material is a better option for surgeons.

If successful, this research could significantly impact the way bleeding is managed in oral and facial surgeries. It could lead to quicker surgeries, fewer complications, and faster recovery times for patients. This would not only benefit individual patients by improving their surgical outcomes but also help healthcare providers by making surgeries more efficient and reducing costs associated with complications and prolonged surgeries.

This study is important for improving surgical techniques and patient care in local hospitals and clinics, and its findings could influence national healthcare practices and policies. Additionally, the results could have a global impact, providing a new, effective solution for managing surgical bleeding in facial and oral procedures worldwide.

By proving the effectiveness of chitosan-based hemostatic materials, this research aims to set a new standard in surgical care, benefiting patients and healthcare systems both locally and globally.